Chemed Corporation (CHE)
$
430.06
+0.90 (0.21%)
Key metrics
Financial statements
Free cash flow per share
24.7983
Market cap
6.3 Billion
Price to sales ratio
2.4777
Debt to equity
0.1314
Current ratio
1.3534
Income quality
1.5052
Average inventory
8.7 Million
ROE
0.2437
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The net total of other income and expenses is $32,972,000.00 reflecting non-core financial activities. The total costs and expenses for the company are $2,064,794,000.00 reflecting its overall spending. Additionally, the net income ratio is 0.12 reflecting the company's profitability margin. The company earned an interest income of $14,610,000.00 showcasing its financial investments. It operates in two segments: VITAS, focused on healthcare services, and Roto-Rooter, which provides plumbing and related services. The company's stock is identified with the symbol 'CHE' in the market, representing its presence within the competitive landscape. With its foundation dating back to 1970 and headquartered in Cincinnati, Ohio, Chemed Corporation continues to adapt and thrive in its service offerings. The stock is priced at $452.25 positioning it in the higher-end market, indicative of its perceived value among investors. However, the stock has a low average trading volume of 181,368.00 indicating lower market activity, which may suggest a niche interest. With a mid-range market capitalization of $6,284,789,289.00 the company is a steady performer in the financial landscape. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and ensuring a diverse range of service offerings. Furthermore, it belongs to the Healthcare sector, driving innovation and growth within its fields of expertise while maintaining a solid reputation among its peers and stakeholders.
Is Chemed Corporation (CHE) a good investment?
Investing in Chemed Corporation (CHE) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
What is Chemed Corporation (CHE)'s stock forecast?
Analysts predict Chemed Corporation stock to fluctuate between $408.42 (low) and $623.61 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Chemed Corporation's market capitalization?
As of 2025-12-12, Chemed Corporation's market cap is $6,284,789,289, based on 14,613,750 outstanding shares.
How does Chemed Corporation compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Chemed Corporation has a Lower Market-Cap, indicating a difference in performance.
Does Chemed Corporation pay dividends?
Chemed Corporation pays dividends. The current dividend yield is 0.51%, with a payout of $0.60 per share.
How can I buy Chemed Corporation (CHE) stock?
To buy Chemed Corporation (CHE) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CHE. Place an order (Market, Limit, etc.).
What is the best time to invest in Chemed Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Chemed Corporation stock ever split?
Chemed Corporation's last stock split was 2:1 on 2005-05-12.
How did Chemed Corporation perform in the last earnings report?
Revenue: $2,431,287,000 | EPS: $20.10 | Growth: 10.99%.
Where can I find Chemed Corporation's investor relations reports?
Visit https://www.chemed.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Chemed Corporation?
You can explore historical data from here
What is the all-time high and low for Chemed Corporation stock?
All-time high: $654.62 (2024-03-15) | All-time low: $403 (2021-10-12).
What are the key trends affecting Chemed Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
defenseworld.net
Boston Partners raised its stake in shares of Chemed Corporation (NYSE: CHE) by 37.1% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,651 shares of the company's stock after purchasing an additional 6,125 shares during the quarter. Boston
seekingalpha.com
Chemtrade Logistics Income Fund ( CHE.UN:CA ) Q3 2025 Earnings Call November 12, 2025 10:00 AM EST Company Participants Rohit Bhardwaj - VP of Finance & CFO Scott Rook - CEO, President & Trustee Conference Call Participants Nikolai Goroupitch Joel Jackson - BMO Capital Markets Equity Research Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to Chemtrade Logistics Income Fund Third Quarter 2025 Conference Call. [Operator Instructions] I would now like to turn the conference call over to Rohit Bhardwaj, Chief Financial Officer.
seekingalpha.com
Chemed Corporation ( CHE ) UBS Global Healthcare Conference 2025 November 11, 2025 2:00 PM EST Company Participants Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Kevin McNamara - CEO, President & Director Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. Thanks, everyone.
globenewswire.com
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
fool.com
Schwartz Investment Counsel sold 28,771 shares of Chemed Corporation; estimated transaction value of approximately $13.03 million based on average third-quarter 2025 pricing Trade represented 0.4% of Schwartz's reportable U.S. equity assets under management as of Q3 2025 Post-trade stake: 111,033 shares valued at $49.71 million as of Q3 2025 Chemed now accounts for 1.67% of AUM as of September 30, 2025, which places it outside the fund's top five holdings
seekingalpha.com
Chemed Corporation ( CHE ) Q3 2025 Earnings Call October 29, 2025 10:00 AM EDT Company Participants Holley Schmidt Kevin McNamara - CEO, President & Director Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Good morning, and thank you for standing by. Welcome to the Chemed Corporation Third Quarter 2025 Earnings Conference Call.
zacks.com
Chemed (CHE) came out with quarterly earnings of $5.27 per share, missing the Zacks Consensus Estimate of $5.39 per share. This compares to earnings of $5.64 per share a year ago.
businesswire.com
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2025 Healthcare Services Conference on Tuesday, September 30, 2025, at approximately 1:50 p.m. (CT) at the 1 Hotel in Nashville. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentatio.
zacks.com
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
See all news
